Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Top 5 Global Health Headlines: India Rejects HIV Patent
India has rejected a patent application for Abbott’s HIV/AIDS treatment Kaletra, reigniting a debate over the country’s patent rules.
Indian Government Rejects Abbott’s Patent Application For Second-Line ARV
HIV Drug to Be Distributed Worldwide
Patent On AIDS Medicine Denied In India; Seen Unlocking Market
India rejects US firms patent for anti-HIV drugs
Indian Patent Office Rejects Abbott’s Kaletra Patent
Patent Denied On AIDS Drug In India
Patent office rejects Abbott’s application on HIV drug
India rejects Abbott patent on Kaletra